Zacks Company Profile for Eton Pharmaceuticals, Inc. (ETON : NSDQ) |
|
|
|
Company Description |
Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.
Number of Employees: 17 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $3.26 |
Daily Weekly Monthly
 |
20 Day Moving Average: 56,800 shares |
Shares Outstanding: 25.22 (millions) |
Market Capitalization: $82.23 (millions) |
Beta: 1.42 |
52 Week High: $8.90 |
52 Week Low: $2.76 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-15.32% |
-4.64% |
12 Week |
-10.44% |
-1.55% |
Year To Date |
-24.01% |
-9.14% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Sean E. Brynjelsen - Chief Executive Officer;President and Director
W. Wilson Troutman - Chief Financial Officer; Treasurer and Secretary
Jennifer M. Adams - Director
Charles J. Casamento - Director
Paul V. Maier - Director
|
|
Peer Information
Eton Pharmaceuticals, Inc. (CORR.)
Eton Pharmaceuticals, Inc. (RSPI)
Eton Pharmaceuticals, Inc. (CGXP)
Eton Pharmaceuticals, Inc. (BGEN)
Eton Pharmaceuticals, Inc. (GTBP)
Eton Pharmaceuticals, Inc. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 29772L108
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/15/22
|
|
Share - Related Items
Shares Outstanding: 25.22
Most Recent Split Date: (:1)
Beta: 1.42
Market Capitalization: $82.23 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $0.05 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-0.05 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/15/22 |
|
|
|
|